Innovimmune Biotherapeutics Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Innovimmune Biotherapeutics General Information

Description

Developer of immunomodulatory drugs intended for the treatment of autoimmune and oncologic diseases. The company is building an innovative product pipeline of novel small molecule NME drug candidates targeting cytokine, chemokine, and nuclear hormone, enabling medical companies to treat cancer diseases in a better manner.

Contact Information

Website
www.innovimmune.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Primary Office
  • 75 Wall Street
  • New York, NY 10005
  • United States
+1 (718) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovimmune Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Startup
1. Grant 01-Jan-2011 00000 Completed Startup
To view Innovimmune Biotherapeutics’s complete valuation and funding history, request access »

Innovimmune Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of immunomodulatory drugs intended for the treatment of autoimmune and oncologic diseases. The company is buil
Drug Delivery
New York, NY
000000000000

000000

e eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000000
Planegg, Germany
000 As of 0000
00000
000000000 00000

000 00

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute i
0000 000000000
Boston, MA
00 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Innovimmune Biotherapeutics Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MorphoSys Formerly PE-Backed Planegg, Germany 000 00000 000000000 00000
000 000000000000 Venture Capital-Backed Boston, MA 00 000.00 0000000000 0 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed New York, NY 0 0000 000000&0 0000
0000000 0000000000 Formerly VC-backed Hampton, NJ 000 00000 00000000 00000
You’re viewing 5 of 40 competitors. Get the full list »

Innovimmune Biotherapeutics Executive Team (1)

Name Title Board Seat Contact Info
Anderson Gaweco MD Founder & Chief Executive Officer
To view Innovimmune Biotherapeutics’s complete executive team members history, request access »

Innovimmune Biotherapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
Start-up NY Accelerator/Incubator Minority 000 0000 000000 0
To view Innovimmune Biotherapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial